Dihydropteridine Reductase Deficiency: A Treatable Neurotransmitter Movement Disorder Masquerading as Refractory Epilepsy Due to Novel Mutation

2018 ◽  
Vol 85 (9) ◽  
pp. 812-813 ◽  
Author(s):  
Vykuntaraju K. Gowda ◽  
Hemadriben Vegda ◽  
Naveen Benakappa ◽  
Asha Benakappa
1990 ◽  
Vol 149 (10) ◽  
pp. 713-715 ◽  
Author(s):  
L. G. Greeves ◽  
R. J. Leeming ◽  
K. Hyland ◽  
S. I. Dempsey ◽  
D. J. Carson

JIMD Reports ◽  
2021 ◽  
Author(s):  
Nicola Vitturi ◽  
Livia Lenzini ◽  
Concetta Luisi ◽  
Miryam Carecchio ◽  
Giorgia Gugelmo ◽  
...  

PEDIATRICS ◽  
1980 ◽  
Vol 65 (4) ◽  
pp. 806-810
Author(s):  
Sheldon Milstien ◽  
Seymour Kaufman ◽  
George K. Summer

Hyperphenylalaninemia due to dihydropteridine reductase deficiency results from the inability to maintain the aromatic amino acid hydroxylase cofactor, tetrahydrobiopterin, in its reduced or active form. Diagnosis of the disease is usually made by direct enzymatic assay on liver biopsies or in cultured skin fibroblasts. Evidence is presented that normal children and classic phenylketonuric children excrete mainly tetrahy-drobiopterin in their urmnes, whereas children with dihydropteridine reductase deficiency excrete only oxidized forms of biopterin. Details of a rapid high performance liquid chromatographic assay for the measurement of the various forms of biopterin in urine are presented. This assay can be used to screen for suspected dihydropteridine reductase mutants.


1983 ◽  
Vol 6 (S2) ◽  
pp. 111-112 ◽  
Author(s):  
J. H. Young ◽  
V. Walker ◽  
P. A. Tippett ◽  
B. E. Clayton ◽  
R. M. Veall

1985 ◽  
Vol 8 (S2) ◽  
pp. 97-98 ◽  
Author(s):  
R. Longhi ◽  
E. Riva ◽  
R. Valsasina ◽  
S. Paccanelli ◽  
M. Giovannini

Pteridines ◽  
1991 ◽  
Vol 3 (1-2) ◽  
pp. 23-24
Author(s):  
R. Cerone ◽  
A. R. Fantasia ◽  
M. C. Schiaffino ◽  
L. Maritano ◽  
C. Romano

Sign in / Sign up

Export Citation Format

Share Document